ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Fujifilm to invest $2bn in cell culture production site in US

Move aims to foster Japanese company's biopharmaceuticals business

Fujifilm Holdings will spend $2 billion to build a large-scale cell culture production site in the U.S., the Japanese company said in a news release on Jan. 7.   © Reuters

TOKYO (Reuters) -- Fujifilm Holdings Corp said on Wednesday it will invest $2 billion to establish new large-scale cell culture production site in the United States.

The new plant will help accelerate growth of the Japanese company's biopharmaceutical contract development and manufacturing business (CDMO), Fujifilm said in a release. The new site will be built near an existing Fujifilm site with production expected to start in the spring of 2025.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more